Jove
Visualize
Contact Us

Related Experiment Videos

Acute otitis media disease management.

M E Pichichero1, J R Casey

  • 1Elmwood Pediatric Group, University of Rochester Medical Center, Rochester, NY 14642, USA. michael_pichichero@urmc.rochester.edu

Minerva Pediatrica
|November 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal colonization in young children.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Poor memory B cell generation contributes to non-protective responses to DTaP vaccine antigens in otitis-prone children.

Clinical and experimental immunology·2015
Same author

Higher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children.

Mucosal immunology·2015
Same author

Divergent mucosal and systemic responses in children in response to acute otitis media.

Clinical and experimental immunology·2014
Same author

Five-year prospective study of paediatric acute otitis media in Rochester, NY: modelling analysis of the risk of pneumococcal colonization in the nasopharynx and infection.

Epidemiology and infection·2014
Same author

CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice.

Infection and immunity·2013
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Accurate diagnosis is key for managing acute otitis media (AOM). Treatment strategies for AOM should consider patient factors, pathogen resistance, and antibiotic effectiveness.

Area of Science:

  • Otolaryngology
  • Pediatrics
  • Infectious Diseases

Background:

  • Accurate diagnosis is crucial for differentiating acute otitis media (AOM) from other middle ear conditions like otitis media with effusion (OME).
  • Classification schemes for AOM, considering factors like persistence, recurrence, and chronicity, influence management decisions.
  • Patient-specific variables such as age, treatment history, and daycare attendance impact AOM management and outcomes.

Purpose of the Study:

  • To outline diagnostic and management strategies for acute otitis media (AOM).
  • To emphasize the importance of accurate diagnosis and appropriate antibiotic selection in AOM management.
  • To discuss factors influencing antibiotic choice, including pathogen resistance and clinical trial data.

Main Methods:

Related Experiment Videos

  • Review of diagnostic criteria for distinguishing AOM from other otitis media subtypes.
  • Analysis of AOM classification schemes and their impact on management.
  • Evaluation of antibiotic pharmacokinetic/pharmacodynamic data, clinical trial results, and resistance patterns.
  • Consideration of patient factors, compliance, and accessibility in treatment selection.

    • Main Results:

    • Amoxicillin is recommended for uncomplicated AOM.
    • Alternative antibiotics are considered for patients with prior antibiotic exposure or those who are otitis-prone.
    • Second-line agents include amoxicillin/clavulanate and various cephalosporins; ceftriaxone or gatifloxacin are third-line options.

    Conclusions:

    • Optimal AOM management requires accurate diagnosis and tailored antibiotic therapy.
    • Antibiotic selection must account for pathogen resistance and susceptibility testing.
    • No single antibiotic or management strategy is universally ideal for all AOM patients.